Cidara Therapeutics, Inc.·4

Mar 29, 5:32 PM ET

Ward Shane 4

4 · Cidara Therapeutics, Inc. · Filed Mar 29, 2023

Insider Transaction Report

Form 4
Period: 2023-03-27
Ward Shane
COO & CLO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-03-27+253,333253,333 total
    Exercise: $1.01Exp: 2033-03-26Common Stock (253,333 underlying)
  • Award

    Common Stock

    2023-03-27+126,667211,243 total
Footnotes (2)
  • [F1]Represents time-based Restricted Stock Units (RSUs) granted on March 27, 2023. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2024, 2025, and 2026, subject to continuous service through each such vesting date.
  • [F2]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 27, 2023.

Documents

1 file
  • 4
    wf-form4_168012552130396.xmlPrimary

    FORM 4